Dr. Ferdinand Massari Named Chief Medical Officer for Deep Genomics

Deep Genomics has hired Dr. Ferdinand Massari as Chief Medical Officer. Ferdinand is a seasoned executive in the pharmaceutical and biotechnology industries, having served in leadership roles with several companies including Shire HGT, Coley Pharmaceutical, Pfizer, sanofi-aventis, and Merck. He is also a trained Internal Medicine Physician, having earned his Doctor of Medicine from Jefferson Medical College of Thomas Jefferson University.

Deep Genomics is a therapeutics company founded on computational biology and artificial intelligence. The AI, genome biology, software engineering and preclinical research team is located in the heart of Toronto, Canada. The clinical development team is based in Boston, Massachusetts.